Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah J Schrieber

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Pharmacokinetics|October 5, 2019
Update on Therapeutic Protein-Drug Interaction: Information in LabelingXing Jing, Ping Ji, Sarah J Schrieber, et al.
Journal of Clinical Pharmacology|November 27, 2024
A Meta-Analysis of the Safety and Immunogenicity of Pharmacokinetic Similarity Studies and Comparative Clinical StudiesPing Ji, Sarah J Schrieber, Rachel Glaser, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2007
Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extractZhiming Wen, Todd E Dumas, Sarah J Schrieber, et al.
Journal of Clinical Pharmacology|August 19, 2021
Impact of Switching on Pharmacokinetics of Therapeutic Biologics and Interchangeability Assessment-A Simulation StudyPing Ji, Yupeng Ren, Liang Li, et al.
Journal of Clinical Pharmacology|May 19, 2025
Comparison of Analysis of Covariance and Analysis of Variance in Pharmacokinetic Similarity StudiesBrett A Martini, Ping Ji, Jiang Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 21, 2008
The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activitySarah J Schrieber, Zhiming Wen, Manoli Vourvahis, et al.
Clinical Pharmacology and Therapeutics|February 3, 2018
Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G-CSF in Breast Cancer PatientsLiang Li, Lian Ma, Sarah J Schrieber, et al.
Journal of Pharmaceutical Sciences|November 6, 2018
Role of Modeling and Simulation in the Development of Novel and Biosimilar Therapeutic ProteinsYow-Ming C Wang, Yaning Wang, Sarah J Schrieber, et al.
Journal of Clinical Pharmacology|July 28, 2023
Evaluation of Truncated AUC as an Alternative Measure to Assess Pharmacokinetic Comparability in Bridging Biologic-Device Using Prefilled Syringes and AutoinjectorsYa-Feng Wen, Ping Ji, Sarah J Schrieber, et al.
Drugs in R&D|September 11, 2020
Comparability Considerations and Challenges for Expedited Development Programs for Biological ProductsSarah J Schrieber, Wendy S Putnam, Edwin Chiu Yuen Chow, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|October 5, 2019
Update on Therapeutic Protein-Drug Interaction: Information in LabelingXing Jing, Ping Ji, Sarah J Schrieber, et al.
Journal of Clinical Pharmacology|November 27, 2024
A Meta-Analysis of the Safety and Immunogenicity of Pharmacokinetic Similarity Studies and Comparative Clinical StudiesPing Ji, Sarah J Schrieber, Rachel Glaser, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2007
Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extractZhiming Wen, Todd E Dumas, Sarah J Schrieber, et al.
Journal of Clinical Pharmacology|August 19, 2021
Impact of Switching on Pharmacokinetics of Therapeutic Biologics and Interchangeability Assessment-A Simulation StudyPing Ji, Yupeng Ren, Liang Li, et al.
Journal of Clinical Pharmacology|May 19, 2025
Comparison of Analysis of Covariance and Analysis of Variance in Pharmacokinetic Similarity StudiesBrett A Martini, Ping Ji, Jiang Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 21, 2008
The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activitySarah J Schrieber, Zhiming Wen, Manoli Vourvahis, et al.
Clinical Pharmacology and Therapeutics|February 3, 2018
Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G-CSF in Breast Cancer PatientsLiang Li, Lian Ma, Sarah J Schrieber, et al.
Journal of Pharmaceutical Sciences|November 6, 2018
Role of Modeling and Simulation in the Development of Novel and Biosimilar Therapeutic ProteinsYow-Ming C Wang, Yaning Wang, Sarah J Schrieber, et al.
Journal of Clinical Pharmacology|July 28, 2023
Evaluation of Truncated AUC as an Alternative Measure to Assess Pharmacokinetic Comparability in Bridging Biologic-Device Using Prefilled Syringes and AutoinjectorsYa-Feng Wen, Ping Ji, Sarah J Schrieber, et al.
Drugs in R&D|September 11, 2020
Comparability Considerations and Challenges for Expedited Development Programs for Biological ProductsSarah J Schrieber, Wendy S Putnam, Edwin Chiu Yuen Chow, et al.
Pageof 3